Dashboard
Manage Tickers

SVRASavara Inc

Nasdaq savarapharma.com


$ 4.79 $ 0.22 (4.79 %)    

Tuesday, 14-May-2024 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 4.81
$ 4.77
$ 0.00 x 0
$ 0.00 x 0
$ 4.76 - $ 4.84
$ 1.97 - $ 5.70
685,328
na
878.07M
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-12-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-06-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 03-14-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 03-24-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-savara-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Sava...
05/13/2024 10:41:18

HC Wainwright & Co. analyst Andrew Fein reiterates Savara (NASDAQ:SVRA) with a Buy and maintains $6 price target.

savara-q1-2024-adj-eps-011-misses-010-estimate
Savara Q1 2024 Adj EPS $(0.11) Misses $(0....
05/09/2024 21:01:00

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 1...

jmp-securities-reiterates-market-outperform-on-savara-maintains-8-price-target
JMP Securities Reiterates Market Outperfor...
05/06/2024 15:08:55

JMP Securities analyst Jonathan Wolleben reiterates Savara (NASDAQ:SVRA) with a Market Outperform and maintains $8 price tar...

jmp-securities-reiterates-market-outperform-on-savara-maintains-8-price-target
JMP Securities Reiterates Market Outperfor...
04/19/2024 16:30:34

JMP Securities analyst Jonathan Wolleben reiterates Savara (NASDAQ:SVRA) with a Market Outperform and maintains $8 price tar...

jmp-securities-reiterates-market-outperform-on-savara-maintains-8-price-target
JMP Securities Reiterates Market Outperfor...
04/18/2024 17:36:14

JMP Securities analyst Jonathan Wolleben reiterates Savara (NASDAQ:SVRA) with a Market Outperform and maintains $8 price tar...

savara-to-present-new-data-on-autoimmune-pulmonary-alveolar-proteinosis-at-the-american-thoracic-society-international-conference-2024
Savara To Present New Data On Autoimmune P...
04/08/2024 12:28:07

Savara's Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAPCompany to Host Indu...

hc-wainwright--co-reiterates-buy-on-savara-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Sava...
03/11/2024 10:49:12

HC Wainwright & Co. analyst Andrew Fein reiterates Savara (NASDAQ:SVRA) with a Buy and maintains $6 price target.

savara-q4-eps-009-beats-010-estimate
Savara Q4 EPS $(0.09) Beats $(0.10) Estimate
03/07/2024 21:25:54

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 ...

piper-sandler-maintains-overweight-on-savara-raises-price-target-to-16
Piper Sandler Maintains Overweight on Sava...
03/04/2024 13:16:04

Piper Sandler analyst Yasmeen Rahimi maintains Savara (NASDAQ:SVRA) with a Overweight and raises the price target from $7 to...

on-feb-13-savara-inc-entered-agreement-with-fujifilm-pursuant-to-which-fujifilm-will-continue-to-provide-development-and-manufacturing-services-related-to-active-pharmaceutical-ingredient-for-the-cos-molgramostim-product-candidate
On Feb 13, Savara Inc Entered Agreement Wi...
02/16/2024 13:38:23

https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1160308/000119312524038108/d775782d8k.htm

jmp-securities-initiates-coverage-on-savara-with-market-outperform-rating-announces-price-target-of-8
JMP Securities Initiates Coverage On Savar...
02/15/2024 12:12:27

JMP Securities analyst Jonathan Wolleben initiates coverage on Savara (NASDAQ:SVRA) with a Market Outperform rating and anno...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/16/2024 21:31:08

rivian-automotive-reports-weak-delivery-figures-joins-joyy-mimedx-group-and-other-big-stocks-moving-lower-on-tuesday
Rivian Automotive Reports Weak Delivery Fi...
01/02/2024 16:47:08

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

savara-introduces-apap-clearpath-a-gm-csf-autoantibody-blood-test-to-detect-autoimmune-pulmonary-alveolar-proteinosis-apap
Savara Introduces aPAP ClearPath, a GM-CSF...
12/21/2023 13:08:59

Savara Inc. (NASDAQ:SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, recen...

hc-wainwright--co-reiterates-buy-on-savara-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Sava...
11/13/2023 16:17:09

HC Wainwright & Co. analyst Andrew Fein reiterates Savara (NASDAQ:SVRA) with a Buy and maintains $6 price target.

savara-q3-eps-010-misses-007-estimate
Savara Q3 EPS $(0.10) Misses $(0.07) Estimate
11/09/2023 22:15:33

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.07) by 4...

5-otc-stocks-with-the-potential-to-explode-in-2024
5 OTC Stocks With The Potential To Explode...
11/08/2023 17:26:24

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from an...

guggenheim-initiates-coverage-on-savara-with-buy-rating-announces-price-target-of-7
Guggenheim Initiates Coverage On Savara wi...
11/07/2023 09:52:22

Guggenheim analyst Daniel Krizay initiates coverage on Savara (NASDAQ:SVRA) with a Buy rating and announces Price Target of $7.

hc-wainwright--co-maintains-buy-on-savara-raises-price-target-to-6
HC Wainwright & Co. Maintains Buy on Savar...
08/14/2023 10:15:49

HC Wainwright & Co. analyst Andrew Fein maintains Savara (NASDAQ:SVRA) with a Buy and raises the price target from $3 to...

savara-q2-eps-007-down-from-006-yoy
Savara Q2 EPS $(0.07) Down From $(0.06) YoY
08/10/2023 21:13:55

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.07) per share. This is a 16.67 percent decrease over losses of $(0.06) pe...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION